Growing Imaging Network InMed operates over 15 imaging centers across the United States, providing a broad platform for medical imaging services such as MRI, CT, X-Ray, Breast MRI, and ultrasound, indicating significant market coverage and potential for equipment upgrades or service expansion.

Pharmaceutical Innovation Focus With a pipeline of proprietary small molecule drug candidates and recent advances like successful pharmacokinetic studies for Alzheimer’s, InMed presents opportunities for collaboration on clinical tools, diagnostics, and specialized medical imaging products tailored to neurological and unmet medical needs.

Strategic Leadership Expansion The appointment of new board members and active shareholder engagement highlights a company in growth mode, potentially open to strategic partnerships and sales initiatives aimed at supporting both their pharmaceutical pipeline and imaging services.

Financial Growth Indicators Reporting revenue between 50 million and 100 million dollars along with recent business updates demonstrates financial stability and increasing operational scale, making the company a viable prospect for equipment supply, service contracts, and technology solutions.

Research and Development Emphasis InMed’s focus on advanced preclinical studies and upcoming clinical trials creates an opportunity for sales of research equipment, laboratory services, and digital tools to support their ongoing drug development pipeline and preclinical testing efforts.